scholarly journals Protective cellular and mucosal immune responses following nasal administration of a whole gamma-irradiated influenza A (subtype H1N1) vaccine adjuvanted with interleukin-28B in a mouse model

Author(s):  
Ailar Sabbaghi ◽  
Mohsen Zargar ◽  
Mohammad Reza Zolfaghari ◽  
Farahnaz Motamedi-Sedeh ◽  
Amir Ghaemi
2009 ◽  
Vol 31 (12) ◽  
pp. 1851-1856 ◽  
Author(s):  
Shaobo Pei ◽  
Ning Xiong ◽  
Yong Zhang ◽  
Shiyun Chen

2021 ◽  
Vol 18 (1) ◽  
Author(s):  
Ailar Sabbaghi ◽  
Masoud Malek ◽  
Sara Abdolahi ◽  
Seyed Mohammad Miri ◽  
Leila Alizadeh ◽  
...  

Abstract Background Several studies on gamma-irradiated influenza A virus (γ-Flu) have revealed its superior efficacy for inducing homologous and heterologous virus-specific immunity. However, many inactivated vaccines, notably in nasal delivery, require adjuvants to increase the quality and magnitude of vaccine responses. Methods To illustrate the impacts of co-administration of the gamma-irradiated H1N1 vaccine with poly (I:C) and recombinant murine CCL21, either alone or in combination with each other, as adjuvants on the vaccine potency, mice were inoculated intranasally 3 times at one-week interval with γ-Flu alone or with any of the three adjuvant combinations and then challenged with a high lethal dose (10 LD50) of A/PR/8/34 (H1N1) influenza virus. Virus-specific humoral, mucosal, and cell-mediated immunity, as well as cytokine profiles in the spleen (IFN-γ, IL-12, and IL-4), and in the lung homogenates (IL-6 and IL-10) were measured by ELISA. The proliferative response of restimulated splenocytes was also determined by MTT assay. Results The findings showed that the co-delivery of the γ-Flu vaccine and CCL21 or Poly (I:C) significantly increased the vaccine immunogenicity compared to the non-adjuvanted vaccine, associated with more potent protection following challenge infection. However, the mice given a combination of CCL21 with poly (I:C) had strong antibody- and cell-mediated immunity, which were considerably higher than responses of mice receiving the γ-Flu vaccine with each adjuvant separately. This combination also reduced inflammatory mediator levels (notably IL-10) in lung homogenate samples. Conclusions The results indicate that adjuvantation with the CCL21 and poly (I:C) can successfully induce vigorous vaccine-mediated protection, suggesting a robust propensity for CCL21 plus poly (I:C) as a potent mucosal adjuvant.


Vaccine ◽  
2014 ◽  
Vol 32 (7) ◽  
pp. 881-887 ◽  
Author(s):  
Inna G. Ovsyannikova ◽  
Sarah J. White ◽  
Beth R. Larrabee ◽  
Diane E. Grill ◽  
Robert M. Jacobson ◽  
...  

Vaccine ◽  
2009 ◽  
Vol 27 (8) ◽  
pp. 1230-1241 ◽  
Author(s):  
H.F. Florindo ◽  
S. Pandit ◽  
L.M.D. Gonçalves ◽  
H.O. Alpar ◽  
A.J. Almeida

2012 ◽  
Vol 13 (1) ◽  
pp. 36 ◽  
Author(s):  
Jian Chen ◽  
Lin Yuan ◽  
Qing Fan ◽  
Fei Su ◽  
Yu Chen ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document